Biblio Discovery — Demo Discovery Service

9 hasil untuk "Samuel Labrecque"

Menampilkan 1–9 · 0,30 detik · RSS

  1. Artikel Jurnal

    L'Assurance autonomie au Québec : une réforme inachevée

    Réjean Hébert; Pauline Gervais; Samuel Labrecque dkk.

    Health Reform Observer - Observatoire des Réformes de Santé, Vol. 4 No. 1 · 2016 · Prancis · DOAJ

    Le projet d'Assurance autonomie (AA) visait à introduire une assurance publique des soins de longue durée dans le système de santé et de services sociaux du Québec. Développé à partir d'une revue des assurances de ce type implantées ailleurs dans le monde, ce projet a fait l'objet de travaux…

    Juga tersedia di: DOAJ

  2. Artikel Jurnal

    Olfactory dysfunction as potential biomarker in neurodegenerative diseases: a narrative review

    Nicolas De Cleene; Katarína Schwarzová; Samuel Labrecque dkk.

    Frontiers in Neuroscience, Vol. 18 · 2025 · Inggris · DOAJ Scopus

    Neurodegenerative diseases represent a group of disorders characterized by progressive degeneration of neurons in the central nervous system, leading to a range of cognitive, motor, and sensory impairments. In recent years, there has been growing interest in the association between…

  3. Artikel Jurnal

    Preanalytical stability of plasma calcitonin gene–related peptide: clinical and research implications

    Florian Frank; Michael Thomas Eller; Sarah Maier dkk.

    The Journal of Headache and Pain, Vol. 26 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Background Calcitonin gene-related peptide (CGRP) is a pivotal molecule in migraine pathophysiology and a major target of current therapeutic strategies. Accurate plasma quantification is essential for biomarker research, yet concerns persist regarding its preanalytical stability…

  4. Artikel Jurnal

    Sex-related differences in Huntington‘s disease: a scoping review

    Greta Hemicker; Katarína Schwarzová; Clancy Cerejo dkk.

    Biology of Sex Differences, Vol. 17 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Background Huntington’s disease (HD) is an autosomal-dominant neurodegenerative disorder and emerging evidence indicates sex-specific differences in disease manifestation and progression. Objective To summarize current evidence on sex-related differences in HD across genetic, clinical…

  5. Artikel Jurnal

    The COVID‐19 Pandemic and Its Influence on Patients With Myotonic Dystrophy Type 1: Lessons Learned

    Vera E. A. Kleinveld; Johanna E. Bruijnes; Samuel Labrecque dkk.

    Brain and Behavior, Vol. 14 No. 11 · 2024 · Inggris · DOAJ Scopus

    ABSTRACT Introduction: Myotonic dystrophy type 1 (DM1) patients might represent a high‐risk population for severe COVID‐19 disease, as cardiopulmonary symptoms are part of the clinical spectrum of DM1. The COVID‐19 pandemic may have impacted DM1 patients. We aimed to determine the effect of the…

  6. Artikel Jurnal Teks lengkap

    Optical Coherence Tomography in Huntington's Disease—A Potential Future Biomarker for Neurodegeneration?

    Clancy Cerejo; Nicolas De Cleene; Elias Mandler dkk.

    Neurology International, Vol. 17 No. 1 · 2025 · Inggris · DOAJ Scopus

    Huntington's disease (HD) is a progressive neurodegenerative disorder for which, until now, only symptomatic treatment has been available. Lately, there have been multiple ongoing clinical trials targeting therapeutic agents for preventing disease onset or slowing disease progression in HD. These…

  7. Artikel Jurnal

    Bridging the gap: sex-specific differences in Huntington’s disease

    Greta Hemicker; Katarína Schwarzová; Samuel Labrecque dkk.

    Orphanet Journal of Rare Diseases, Vol. 21 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Introduction Huntington’s disease (HD) is a progressive neurodegenerative disorder caused by an expanded cytosine-adenine-guanine (CAG) trinucleotide repeat on chromosome 4. Exploring sex-related differences in disease manifestation may improve understanding and guide more tailored…

  8. Artikel Jurnal

    IDEA-FAST clinical study protocol: Identifying digital end-points of fatigue, sleep quality and daytime sleepiness in N = 2000

    Walter Maetzler; Stefan Avey; Andrea Pilotto dkk.

    Digital Health, Vol. 12 · 2026 · Inggris · DOAJ Scopus

    Background Fatigue, impaired sleep quality and daytime sleepiness, common in neurodegenerative and immune-mediated diseases, are debilitating and have serious societal and economic implications. Currently, measurement of these symptoms largely relies on self-reported questionnaires, which are…